Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil once-daily for benign prostatic hyperplasia symptoms in Asian men
jRCT2080221678Phase 3
- Sponsor
- Eli Lilly and Company
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in benign prostatic hyperplasia (BPH) comparing Tadalafil 5 mg once daily with Placebo once daily (2 arms).
02
Drugs
tadalafil
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on jRCT2080221678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221678.